meta-analysis | Q815382 |
scholarly article | Q13442814 |
P50 | author | Allison R Pettit | Q57051141 |
Nicholas M Fisk | Q44813090 | ||
Pascale V Guillot | Q46925623 | ||
P2093 | author name string | Jennifer M Ryan | |
Jerry K Y Chan | |||
P2860 | cites work | Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4 | Q22008002 |
Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues | Q24293962 | ||
Expression profile of the embryonic markers nanog, OCT-4, SSEA-1, SSEA-4, and frizzled-9 receptor in human periodontal ligament mesenchymal stem cells | Q24311824 | ||
Core transcriptional regulatory circuitry in human embryonic stem cells | Q24322016 | ||
Endothelial differentiation of amniotic fluid-derived stem cells: synergism of biochemical and shear force stimuli | Q24631307 | ||
Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells | Q25256954 | ||
Embryonic stem cell lines derived from human blastocysts | Q27861010 | ||
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
A perivascular origin for mesenchymal stem cells in multiple human organs | Q28131808 | ||
Eleven daughters of NANOG | Q28270165 | ||
A hypothesis for an embryonic origin of pluripotent Oct-4(+) stem cells in adult bone marrow and other tissues | Q28291967 | ||
Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells | Q28590205 | ||
Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors | Q30160342 | ||
Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord | Q30160386 | ||
Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol | Q30164154 | ||
Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential | Q30164557 | ||
Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. | Q30167892 | ||
Mesenchymal progenitor cells in human umbilical cord blood | Q30168979 | ||
Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research | Q31162560 | ||
Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vitro | Q33274890 | ||
Stem cell marker OCT3/4 in tumor biology and germ cell tumor diagnostics: history and future | Q33281673 | ||
Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells | Q33307769 | ||
Unrestricted somatic stem cells from human umbilical cord blood grow in serum-free medium as spheres | Q33518056 | ||
Constitutive expression of pluripotency-associated genes in mesodermal progenitor cells (MPCs). | Q33548649 | ||
Persistent circulating human insulin in sheep transplanted in utero with human mesenchymal stem cells | Q33787406 | ||
Derivation of Clinically Compliant MSCs from CD105+, CD24− Differentiated Human ESCs | Q56915439 | ||
Fetal Mesenchymal Stem-Cell Engraftment in Bone after In Utero Transplantation in a Patient with Severe Osteogenesis Imperfecta | Q58789209 | ||
Mesenchymal stem cells from umbilical cord: Do not discard the cord! | Q60198956 | ||
Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers | Q60634398 | ||
Identification of stem cell marker-positive cells by immunofluorescence in term human amnion | Q64355635 | ||
Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation | Q73756569 | ||
Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord | Q78799982 | ||
Isolation of multipotent mesenchymal stem cells from umbilical cord blood | Q79202796 | ||
CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential | Q79334969 | ||
Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta | Q79791852 | ||
Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells | Q79998249 | ||
Pluripotent marker expression and differentiation of human second trimester Mesenchymal Stem Cells | Q80842875 | ||
Revisiting OCT4 expression in peripheral blood mononuclear cells | Q81432216 | ||
Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta | Q81529154 | ||
In vivo osteoprogenitor potency of human stromal cells from different tissues does not correlate with expression of POU5F1 or its pseudogenes | Q81618085 | ||
Multipotent mesenchymal stem cells from human placenta: critical parameters for isolation and maintenance of stemness after isolation | Q82343448 | ||
Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis | Q82437161 | ||
Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration | Q82754466 | ||
Recruitment of host's progenitor cells to sites of human amniotic fluid stem cells implantation | Q83769039 | ||
Human embryonic and fetal mesenchymal stem cells differentiate toward three different cardiac lineages in contrast to their adult counterparts | Q34023300 | ||
Stemness Evaluation of Mesenchymal Stem Cells from Placentas According to Developmental Stage: Comparison to Those from Adult Bone Marrow | Q34159690 | ||
Identification of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristics | Q34529163 | ||
Isolation of amniotic stem cell lines with potential for therapy | Q34598404 | ||
Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker. | Q34611461 | ||
Human mesenchymal stem cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion | Q34625007 | ||
Differential immunomodulatory effects of fetal versus maternal multipotent stromal cells | Q34880677 | ||
Fetal stem cells from extra-embryonic tissues: do not discard | Q35458346 | ||
Wharton's jelly-derived cells are a primitive stromal cell population | Q35849157 | ||
Umbilical cord transplantation: epilogue | Q35852921 | ||
An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells | Q36510839 | ||
Fetal stem cells: betwixt and between | Q36661718 | ||
The developmental deposition of epiblast/germ cell-line derived cells in various organs as a hypothetical explanation of stem cell plasticity? | Q36723465 | ||
Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells | Q36987698 | ||
Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors. | Q37470920 | ||
Isolation of mesenchymal stem cells from human placental decidua basalis and resistance to hypoxia and serum deprivation | Q37547015 | ||
Differentiation and migration properties of human foetal umbilical cord perivascular cells: potential for lung repair | Q37580745 | ||
Successful vitrification of human amnion-derived mesenchymal stem cells. | Q38500655 | ||
Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells | Q38512406 | ||
Lentivirus-modified human umbilical cord mesenchymal stem cells maintain their pluripotency | Q39766924 | ||
Human chorion-derived stem cells: changes in stem cell properties during serial passage | Q39794066 | ||
OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. | Q39940745 | ||
Characterization and genetic manipulation of human umbilical cord vein mesenchymal stem cells: potential application in cell-based gene therapy | Q39993682 | ||
Transplantation of human amniotic cells exerts neuroprotection in MPTP-induced Parkinson disease mice | Q40000721 | ||
Fetal mesenchymal stem cells derived from human umbilical cord sustain primitive characteristics during extensive expansion | Q40034474 | ||
Characterization and differentiation of equine umbilical cord-derived matrix cells | Q40180384 | ||
Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung | Q40233552 | ||
The human OCT-4 isoforms differ in their ability to confer self-renewal | Q40236055 | ||
Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study | Q40321403 | ||
Oct4 pseudogenes are transcribed in cancers | Q40361157 | ||
Isolation of multipotent cells from human term placenta. | Q40457999 | ||
Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? | Q40578057 | ||
In line with our ancestors: Oct-4 and the mammalian germ | Q40993926 | ||
Isolation of mesenchymal stem cells with neurogenic potential from the mesoderm of the amniotic membrane | Q43136672 | ||
Multipotent mesenchymal stem cells from amniotic fluid originate neural precursors with functional voltage-gated sodium channels | Q44280495 | ||
Isolation and characterization of true mesenchymal stem cells derived from human term decidua capable of multilineage differentiation into all 3 embryonic layers | Q44782196 | ||
Generation of mesenchymal stem cell from human umbilical cord tissue using a combination enzymatic and mechanical disassociation method | Q45239439 | ||
Human amniotic mesenchymal cells have some characteristics of cardiomyocytes | Q45309359 | ||
The POU5F1P1 pseudogene encodes a putative protein similar to POU5F1 isoform 1. | Q45824965 | ||
Isolation and characterization of mesenchymal cells from human fetal membranes | Q46882275 | ||
Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice | Q46925534 | ||
Neo-vascularization and bone formation mediated by fetal mesenchymal stem cell tissue-engineered bone grafts in critical-size femoral defects. | Q47172133 | ||
Ex vivo characteristics of human amniotic membrane-derived stem cells | Q48012278 | ||
Multiple retropseudogenes from pluripotent cell-specific gene expression indicates a potential signature for novel gene identification | Q48156220 | ||
Differentiation of human fetal mesenchymal stem cells into cells with an oligodendrocyte phenotype. | Q48712762 | ||
Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease | Q48730943 | ||
POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. | Q50645942 | ||
Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. | Q50693998 | ||
Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. | Q50790713 | ||
Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. | Q51067770 | ||
Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. | Q51155330 | ||
Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration. | Q51210701 | ||
Immunologic properties of human fetal mesenchymal stem cells. | Q51718048 | ||
Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. | Q51812638 | ||
Isolation and characterization of mesenchymal stem cells from the amniotic membrane. | Q51817620 | ||
The biological characteristics of human third trimester amniotic fluid stem cells. | Q51822929 | ||
Comparative growth behaviour and characterization of stem cells from human Wharton's jelly. | Q51970373 | ||
Widespread distribution and muscle differentiation of human fetal mesenchymal stem cells after intrauterine transplantation in dystrophic mdx mouse. | Q51998594 | ||
Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. | Q52001009 | ||
Human placenta-derived cells have mesenchymal stem/progenitor cell potential. | Q52087798 | ||
Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties. | Q53101655 | ||
Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane. | Q53307976 | ||
Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells. | Q53531295 | ||
Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cel | Q54388224 | ||
Comparison of mesenchymal stem cells from human placenta and bone marrow. | Q54713607 | ||
Isolation and identification of mesenchymal stem cells from human fetal pancreas. | Q54771966 | ||
Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. | Q55041824 | ||
Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles. | Q55052510 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pluripotency | Q1894941 |
mesenchymal stem cell | Q1922379 | ||
P304 | page(s) | 408-421 | |
P577 | publication date | 2013-08-01 | |
P1433 | published in | Stem Cell Reviews and Reports | Q7607285 |
P1476 | title | Unravelling the pluripotency paradox in fetal and placental mesenchymal stem cells: Oct-4 expression and the case of The Emperor's New Clothes | |
P478 | volume | 9 |